DOI:
10.1055/s-00000140
Pädiatrie up2date
LinksClose Window
References
Moricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dordelmann M. et al.
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008; 111 (9): 4477-4489
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.